메뉴 건너뛰기




Volumn 93, Issue 2, 1998, Pages 212-216

Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: Experience from clinical practice in a population with a high frequency of metronidazole resistance

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH NITRATE; CARBON 14; CIMETIDINE; IMMUNOGLOBULIN G; METRONIDAZOLE; OXYTETRACYCLINE; RANITIDINE; UREA;

EID: 0032008334     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00212.x     Document Type: Article
Times cited : (27)

References (27)
  • 1
    • 0030088953 scopus 로고    scopus 로고
    • Treatment of Helicobacter pylori infection: A review of the world literature
    • 1. van der Hulst RWM, Keller JJ, Rauws EAJ, et al. Treatment of Helicobacter pylori infection: A review of the world literature. Helicobacter 1996;1:6-19.
    • (1996) Helicobacter , vol.1 , pp. 6-19
    • Van Der Hulst, R.W.M.1    Keller, J.J.2    Rauws, E.A.J.3
  • 2
    • 0029979323 scopus 로고    scopus 로고
    • Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain)
    • 2. Tefera S, Berstad A, Bang CJ, et al. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain). Am J Gastroenterol 1996;91:935-41.
    • (1996) Am J Gastroenterol , vol.91 , pp. 935-941
    • Tefera, S.1    Berstad, A.2    Bang, C.J.3
  • 3
    • 0030604372 scopus 로고    scopus 로고
    • Consensus statement: Medical treatment of peptic ulcer disease
    • 3. The American College of Gastroenterology. Consensus statement: Medical treatment of peptic ulcer disease (practice guidelines). JAMA 1996;275:622-9.
    • (1996) JAMA , vol.275 , pp. 622-629
  • 4
    • 0030067239 scopus 로고    scopus 로고
    • Triple therapy vs. Amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: A multicenter, prospective, randomized, controlled study of efficacy and side effects
    • 4. Thijs JC, van Zwet AA, Moolenaar W, et al. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: A multicenter, prospective, randomized, controlled study of efficacy and side effects. Am J Gastroenterol 1996;91:93-7.
    • (1996) Am J Gastroenterol , vol.91 , pp. 93-97
    • Thijs, J.C.1    Van Zwet, A.A.2    Moolenaar, W.3
  • 5
    • 0028111558 scopus 로고
    • 10 Days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year
    • 5. Berstad A, Berstad K, Hatlebakk JG, et al. 10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year. Tidsskr Nor Laegeforen 1994;114:2477-9.
    • (1994) Tidsskr Nor Laegeforen , vol.114 , pp. 2477-2479
    • Berstad, A.1    Berstad, K.2    Hatlebakk, J.G.3
  • 6
    • 0026521918 scopus 로고
    • Factors influencing the eradication of Helicobacter pylori with triple therapy
    • 6. Grahams DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6.
    • (1992) Gastroenterology , vol.102 , pp. 493-496
    • Grahams, D.Y.1    Lew, G.M.2    Malaty, H.M.3
  • 7
    • 0029020465 scopus 로고
    • The best therapy for Helicobacter pylori infection: Should efficacy or side-effect profile determine our choice?
    • 7. de Boer WA, Tytgat GN. The best therapy for Helicobacter pylori infection: Should efficacy or side-effect profile determine our choice? Scand J Gastroenterol 1995;30:401-7.
    • (1995) Scand J Gastroenterol , vol.30 , pp. 401-407
    • De Boer, W.A.1    Tytgat, G.N.2
  • 8
    • 0029901103 scopus 로고    scopus 로고
    • How to treat Helicobacter pylori infection - Should treatment strategies be based on testing bacterial susceptibility? a personal viewpoint
    • 8. de Boer WA, Tytgat GNJ. How to treat Helicobacter pylori infection - should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint (review). Eur J Gastroenterol Hepatol 1996;8:709-16.
    • (1996) Eur J Gastroenterol Hepatol , vol.8 , pp. 709-716
    • De Boer, W.A.1    Tytgat, G.N.J.2
  • 9
    • 0030891435 scopus 로고    scopus 로고
    • A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: A prospective randomized 1-yr follow-up study
    • 9. Lerang F, Moum B, Ragnhildstveit E, et al. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: A prospective randomized 1-yr follow-up study. Am J Gastroenterol 1997;92:653-8.
    • (1997) Am J Gastroenterol , vol.92 , pp. 653-658
    • Lerang, F.1    Moum, B.2    Ragnhildstveit, E.3
  • 10
    • 0030223132 scopus 로고    scopus 로고
    • Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 study
    • 10. Lind T, Veldhuyzen van Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 study. Helicobacter 1996;1:138-44.
    • (1996) Helicobacter , vol.1 , pp. 138-144
    • Lind, T.1    Veldhuyzen Van Zanten, S.2    Unge, P.3
  • 12
    • 0028898507 scopus 로고
    • 1-Week low-dose triple therapy: New standards for Helicobacter pylori treatment
    • 12. Goddard A, Logan R. 1-week low-dose triple therapy: New standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995; 7:1-3.
    • (1995) Eur J Gastroenterol Hepatol , vol.7 , pp. 1-3
    • Goddard, A.1    Logan, R.2
  • 13
    • 0031031362 scopus 로고    scopus 로고
    • Current European concepts in the management of Helicobacter pylori infection - The Maastricht consensus report
    • 13. Malfertheiner P, Megraud F, O'Morain C, et al. Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report. Eur J Gastroenterol Hepatol 1997;9:1-2.
    • (1997) Eur J Gastroenterol Hepatol , vol.9 , pp. 1-2
    • Malfertheiner, P.1    Megraud, F.2    O'Morain, C.3
  • 14
    • 0025907230 scopus 로고
    • Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori
    • 14. Thillainayagam AV, Arvind AS, Cook RS, et al. Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori. Gut 1991;32:467-9.
    • (1991) Gut , vol.32 , pp. 467-469
    • Thillainayagam, A.V.1    Arvind, A.S.2    Cook, R.S.3
  • 16
    • 0028788903 scopus 로고
    • A simple, rapid, and highly reliable capsule-based 14C urea breath test for diagnosis of Helicobacter pylori infection
    • 16. Hamlet AK, Erlandsson KI, Olbe L, et al . A simple, rapid, and highly reliable capsule-based 14C urea breath test for diagnosis of Helicobacter pylori infection. Scand J Gastroenterol 1995;30:1058-63.
    • (1995) Scand J Gastroenterol , vol.30 , pp. 1058-1063
    • Hamlet, A.K.1    Erlandsson, K.I.2    Olbe, L.3
  • 17
    • 0026577576 scopus 로고
    • Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori
    • 17. Kosunen T, Seppala K, Sarna S, et al. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
    • (1992) Lancet , vol.339 , pp. 893-895
    • Kosunen, T.1    Seppala, K.2    Sarna, S.3
  • 18
    • 0027301348 scopus 로고
    • Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy
    • 18. Hirschl AM, Branstatter G, Dragosics B, et al. Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy. J Infect Dis 1993;168:763-6.
    • (1993) J Infect Dis , vol.168 , pp. 763-766
    • Hirschl, A.M.1    Branstatter, G.2    Dragosics, B.3
  • 20
    • 0029840245 scopus 로고    scopus 로고
    • Helicobacter pylori eradication in clinical practice: One-week low-dose triple therapy is preferable to classical bismuth based triple therapy
    • 20. Goddard AF, Spiller RC. Helicobacter pylori eradication in clinical practice: One-week low-dose triple therapy is preferable to classical bismuth based triple therapy. Aliment Pharmacol Ther 1996;10:1009-13.
    • (1996) Aliment Pharmacol Ther , vol.10 , pp. 1009-1013
    • Goddard, A.F.1    Spiller, R.C.2
  • 21
    • 0029949471 scopus 로고    scopus 로고
    • Choosing the best anti-Helicobacter pylori therapy: Effect of antimicrobial resistance
    • 21. Graham DY, de Boer WA, Tytgat GN. Choosing the best anti-Helicobacter pylori therapy: Effect of antimicrobial resistance. Am J Gastroenterol 1996;91:1072-6.
    • (1996) Am J Gastroenterol , vol.91 , pp. 1072-1076
    • Graham, D.Y.1    De Boer, W.A.2    Tytgat, G.N.3
  • 22
    • 0029775120 scopus 로고    scopus 로고
    • Metronidazole-resistant H. pylori - of questionable clinical importance
    • 22. Walt RP. Metronidazole-resistant H. pylori - of questionable clinical importance. Lancet 1996;348:489-90.
    • (1996) Lancet , vol.348 , pp. 489-490
    • Walt, R.P.1
  • 23
    • 0031467306 scopus 로고    scopus 로고
    • Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy
    • 23. Lerang F, Moum B, Haug JB, et al. Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy. Scand J Gastroenterol 1997;32:1209-14.
    • (1997) Scand J Gastroenterol , vol.32 , pp. 1209-1214
    • Lerang, F.1    Moum, B.2    Haug, J.B.3
  • 24
    • 0002972216 scopus 로고
    • Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori
    • 24. Xia H, Buckley M, Hyde D, et al. Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori. Gut 1995;37(suppl 2):A55.
    • (1995) Gut , vol.37 , Issue.SUPPL. 2
    • Xia, H.1    Buckley, M.2    Hyde, D.3
  • 25
    • 0029850832 scopus 로고    scopus 로고
    • One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: Differing efficacy in previously treated and untreated patients
    • 25. Moshkowitz M, Konikoff FM, Peled Y, et al. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: Differing efficacy in previously treated and untreated patients. Aliment Pharmacol Ther 1996;10:1015-9.
    • (1996) Aliment Pharmacol Ther , vol.10 , pp. 1015-1019
    • Moshkowitz, M.1    Konikoff, F.M.2    Peled, Y.3
  • 26
    • 0002602020 scopus 로고    scopus 로고
    • High cure rate of H. pylori infection by one-week therapy with omeprazole, metronidazole and clarithromycin despite a negative impact by metronidazole resistance
    • 26. Peitz U, Nusch A, Tillenburg B, et al. High cure rate of H. pylori infection by one-week therapy with omeprazole, metronidazole and clarithromycin despite a negative impact by metronidazole resistance. Gut 1996;39(suppl 2):A5.
    • (1996) Gut , vol.39 , Issue.SUPPL. 2
    • Peitz, U.1    Nusch, A.2    Tillenburg, B.3
  • 27
    • 0029091042 scopus 로고
    • Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori
    • 27. Moayyedi P, Sahay P, Tompkins DS, et al. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995;7:835-40.
    • (1995) Eur J Gastroenterol Hepatol , vol.7 , pp. 835-840
    • Moayyedi, P.1    Sahay, P.2    Tompkins, D.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.